Szilard Kiss

Title: Szilard Kiss: Innovator in T Cell Therapy

Introduction

Szilard Kiss is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of medical therapies. He holds 2 patents that focus on innovative methods for treating cytomegalovirus (CMV) retinitis, particularly in patients with compromised immune systems.

Latest Patents

His latest patents include groundbreaking methods of treating CMV retinitis by T cell therapy. These methods involve administering a population of allogeneic T cells that comprise CMV-specific T cells to human patients who are either infected with human immunodeficiency virus (HIV) or have received a solid organ transplant. This innovative approach aims to enhance the immune response in vulnerable patients, providing a new avenue for treatment.

Career Highlights

Szilard Kiss has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Cornell University. His work at these organizations has allowed him to collaborate with leading experts in the field and contribute to advancements in cancer and infectious disease therapies.

Collaborations

Some of his notable coworkers include Richard John O'Reilly and Susan Elizabeth Prockop. Their collaborative efforts have furthered research and development in the area of T cell therapies.

Conclusion

Szilard Kiss is a key figure in the development of innovative treatments for CMV retinitis, demonstrating the impact of his work on patient care and medical research. His contributions continue to shape the future of immunotherapy.